Karen van der Weide

462 citations
11 papers · 324 indexed · h-index 8
Topics
Acute Myeloid Leukemia Research (4 papers)Cancer, Lipids, and Metabolism (3 papers)Pharmacogenetics and Drug Metabolism (3 papers)
Partner nations
NetherlandsItalyPakistan

In The Last Decade

Karen van der Weide

11 papers receiving 320 citations

Peers

Karen van der Weide
Comparison fields: 5 of 62
  • Molecular Biology 117
  • Pharmacology 69
  • Cancer Research 66
  • Psychiatry and Mental health 64
  • Hematology 60
Replace Rubén Fernández‐Rodríguez with:
Rubén Fernández‐Rodríguez Spain
Haojun Yang China
Katarina Rask Sweden
Gillian Moore Ireland
Gaofeng Zheng China
Zakar Mnjoyan United States
Muhammad Yassin Israel
Stacy L. Throm United States
Christine Mall United States
Cheng-Chin Kuo Taiwan
Karen van der Weide relative to Rubén Fernández‐Rodríguez Spain Rubén Fernández‐Rodríguez's profile →
Citations per field
00.5×5.8×
Rubén Fernández‐Rodríguez · 1×
Citations per year

Countries citing papers authored by Karen van der Weide

Since Specialization
Citations

This map shows the geographic impact of Karen van der Weide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen van der Weide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen van der Weide more than expected).

Fields of papers citing papers by Karen van der Weide

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen van der Weide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen van der Weide. The network helps show where Karen van der Weide may publish in the future.

Co-authorship network of co-authors of Karen van der Weide

This figure shows the co-authorship network connecting the top 25 collaborators of Karen van der Weide. A scholar is included among the top collaborators of Karen van der Weide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen van der Weide. Karen van der Weide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 6
2 23
3 55
4 45
5 3
6 14
7 72
8 1
9 22
10 11
11 72

About Karen van der Weide

Karen van der Weide is a scholar working on Hematology, Pharmacology and Cancer Research, having authored 11 papers that have together received 324 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Cancer, Lipids, and Metabolism (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Pharmacology (69 citations), Hematology (60 citations) and Biological Psychiatry (12 citations). Karen van der Weide has collaborated with scholars based in Netherlands, Italy and Pakistan. Frequent co-authors include Jan van der Weide, Edo Vellenga, Elisabeth G.E. de Vries, Jan Jacob Schuringa, Gerwin Huls, Folkert Kuipers, André B. Mulder, Hendrik J.M. de Jonge, Carolien M. Woolthuis and AnneMarie Vos. Their work appears in journals such as Blood, Clinical Cancer Research and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026